BIM
WST icon

Bogle Investment Management’s West Pharmaceutical WST Stock Holding History

Bogle Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-70,815
Closed -$10.8M – 429
2020
Q1 		$10.8M Buy
70,815
+53,879
+318% +$8.29M 1.13% 14
2019
Q4 		$2.55M Sell
16,936
-1,877
-10% -$273K 0.24% 127
2019
Q3 		$2.67M Buy
+18,813
New +$2.59M 0.23% 114

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Bogle Investment Management's WST Position: Q2 2020 in Review

Bogle Investment Management sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 70,815 shares — an estimated $10.8M sold.

Bogle Investment Management first reported a position in WST in Q3 2019 and held it in 3 quarters. The position peaked at $10.8M in Q1 2020. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Bogle Investment Management reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Bogle Investment Management sold 70,815 West Pharmaceutical shares in Q2 2020, an estimated $10.8M.
  • Bogle Investment Management first reported a position in West Pharmaceutical in Q3 2019 and held it in 3 quarters.
  • Bogle Investment Management's West Pharmaceutical position peaked at $10.8M in Q1 2020.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.